Common Names
Geographic Range: Native to India and Sri Lanka; cultivated across South and Southeast Asia.
Known Contraindications
1
Compounds
1
Traditions
1
Treatments
4
Conditions
C=C1CCC2(C(C)CCC3(C)C2CC=C2C4CC(O)(CO)CC4(CO)CCC23)C1CYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | moderate inhibitor |
| CYP2C9 | weak inhibitor |
| CYP2D6 | no significant interaction |
| CYP3A4 | moderate inhibitor |
| CYP2C19 | weak substrate |
| clinical_note | Moderate CYP1A2 and CYP3A4 inhibition — caution with theophylline, warfarin. May potentiate antihypertensive and anticoagulant effects. |